Keyphrases
Matrix metalloproteinase-2 (MMP-2)
100%
Receptor 1
100%
Taxanes
100%
Human Prostate Cancer Cells
100%
Castration-resistant Prostate Cancer
36%
Matrix metalloproteinase-9 (MMP-9)
18%
Knockdown
18%
Novel Therapeutic Targets
18%
PC-3 Cells
18%
Resistant Prostate Cancer
18%
Protein Level
9%
Phosphorylation
9%
Expression Level
9%
Signaling Pathway
9%
Role in Cancer
9%
ERK2
9%
Chemokines
9%
Rac1
9%
Initial Diagnosis
9%
CCL5
9%
SiRNA Knockdown
9%
Cancer Invasion
9%
Paclitaxel-resistant
9%
Multidrug-resistant
9%
Cdc42
9%
Prostate Cancer Patients
9%
Cancer Metastasis
9%
Prostate Cancer Cells
9%
Prostate Cancer Screening
9%
Taxane Resistance
9%
MEK1
9%
Matrigel Invasion Assay
9%
Taxane-based Chemotherapy
9%
Negative Prostate Biopsy
9%
Chemokine Ligands
9%
Medicine and Dentistry
Cancer Cell
100%
Receptor
100%
Secretion (Process)
100%
Prostate Cancer
100%
Gelatinase A
100%
Gelatinase B
18%
Gamma Chemokine
18%
Small Interfering RNA
9%
Signal Transduction
9%
Enzyme Linked Immunosorbent Assay
9%
Mitogen Activated Protein Kinase 3
9%
Metastatic Carcinoma
9%
Chemokine
9%
Paclitaxel
9%
Cell Invasion
9%
Matrigel
9%
Prostate Biopsy
9%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
100%
Eicosanoid Receptor
100%
Gelatinase A
100%
MMP2
100%
Secretion (Process)
100%
Chemokine
27%
Gelatinase B
18%
MMP9
18%
Messenger RNA
9%
Signal Transduction
9%
Small Interfering RNA
9%
Cell Invasion
9%
Pharmacology, Toxicology and Pharmaceutical Science
Receptor
100%
Prostate Cancer
100%
Gelatinase A
100%
Taxane
100%
Gelatinase B
18%
Gamma Chemokine
18%
Malignant Neoplasm
9%
Enzyme-Linked Immunosorbent Assay
9%
Small Interfering RNA
9%
Mitogen Activated Protein Kinase 3
9%
Chemotherapy
9%
Paclitaxel
9%
Chemokine
9%
Matrigel
9%
Immunology and Microbiology
Cancer Cell
100%
Secretion (Process)
100%
Prostate
100%
Gamma Chemokine
40%
Signal Transduction
20%
ELISA
20%
Chemokine
20%
Cell Invasion
20%